More than 30 years after Viagra hit the market for men, a new treatment looks to offer the same for women in need of a little help in the bedroom.
Couples are turning to all sorts of things to reignite their fire, ranging from the innocent introduction of new positions, to the more outrageous modern trends such as hotwifing and soft-swapping.
As we grow older and struggle to cope with the many stresses of life, it can sometimes be difficult to fit in a time to be intimate, and there's perhaps an increased pressure to make those fleeting moments memorable.
Sadly, the more pressure a person feels to perform, the more likely their body is to let them down, and that's where a little blue pill has been helping out men since 1989.
Advert
There's a whole conversation to be had about why men's needs have been put before women's - not just in the bedroom but in wider society - for so long, but scientists at women’s health biotech group Daré Bioscience have been working hard to change that.
Their product 'DARE to PLAY' has officially hit the shelves in several US states and promises to revolutionise the sexual experience for more than 20 million women in America alone, as it promises to increase blood flow in the vagina and improve sexual arousal in just 10 to 15 minutes.
“When Viagra was approved in 1998, it revolutionised sexual medicine for men. But for women, comparable progress on enhancing the natural arousal sensations has stalled for nearly three decades,” CEO Sabrina Martucci Johnson.
“We believe DARE to PLAY represents a long overdue correction, giving women an option to reconnect with their own bodies, their pleasure, and their confidence, using science that finally recognises their needs.”
The product uses sildenafil, which is the same ingredient used in Viagra, to increase blood flow to the penis and help create an erection and can be administered just minutes before you anticipate things getting hot and heavy.
“As more women speak openly about their sexual health, the need for research-backed solutions has never been greater,” said Dr. Irwin Goldstein, Director of San Diego Sexual Medicine and a founder of ISSWSH.
“Daré’s commitment to both clinical integrity and timely access ensures women who need it don’t have to wait to benefit from this innovation.”
The good news is that no side effects were noticed after the product underwent a clinical trial, but it should still only be applied once a day, in case you were thinking of going a little wild.
It is currently available for pre-order in Connecticut, Florida, Indiana, Missouri, New Hampshire, New Jersey, Oregon, Pennsylvania, Rhode Island and Utah, but will be rolled out across the rest of the US this month and in early 2026.
And if it's a roaring success, you can imagine that it's only a matter of time until it's put on sale in the rest of the world.
Topics: Sex and Relationships, Health, US News
James Moorhouse